img

Global Inactivated Polio and Rabies Vaccines Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Polio and Rabies Vaccines Market Insights, Forecast to 2034

Polio vaccines can be classified into two typesthe inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.
Global Inactivated Polio and Rabies Vaccines market is expected to reach to US$ 681 million in 2024, with a positive growth of %, compared with US$ 635 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Inactivated Polio and Rabies Vaccines industry is evaluated to reach US$ 1051 million in 2029. The CAGR will be 7.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Inactivated Polio and Rabies Vaccines market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Inactivated Polio and Rabies Vaccines market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer
Segment by Type
Inactivated Polio Vaccine
Inactivated Rabies Vaccine

Segment by Application


Pediatrics
Adults

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Inactivated Polio and Rabies Vaccines plant distribution, commercial date of Inactivated Polio and Rabies Vaccines, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Inactivated Polio and Rabies Vaccines introduction, etc. Inactivated Polio and Rabies Vaccines Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Inactivated Polio and Rabies Vaccines
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Inactivated Polio and Rabies Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Polio Vaccine
1.2.3 Inactivated Rabies Vaccine
1.3 Market by Application
1.3.1 Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pediatrics
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Inactivated Polio and Rabies Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region
2.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2024)
2.2.3 Global Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029)
2.2.4 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Inactivated Polio and Rabies Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Inactivated Polio and Rabies Vaccines Sales by Region
2.4.1 Global Inactivated Polio and Rabies Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024)
2.4.3 Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029)
2.4.4 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers
3.1.1 Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers (2018-2024)
3.1.2 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Polio and Rabies Vaccines in 2022
3.2 Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers
3.2.1 Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Inactivated Polio and Rabies Vaccines Revenue in 2022
3.3 Global Key Players of Inactivated Polio and Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Inactivated Polio and Rabies Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inactivated Polio and Rabies Vaccines Sales by Type
4.1.1 Global Inactivated Polio and Rabies Vaccines Historical Sales by Type (2018-2024)
4.1.2 Global Inactivated Polio and Rabies Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Polio and Rabies Vaccines Revenue by Type
4.2.1 Global Inactivated Polio and Rabies Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global Inactivated Polio and Rabies Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Polio and Rabies Vaccines Price by Type
4.3.1 Global Inactivated Polio and Rabies Vaccines Price by Type (2018-2024)
4.3.2 Global Inactivated Polio and Rabies Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Inactivated Polio and Rabies Vaccines Sales by Application
5.1.1 Global Inactivated Polio and Rabies Vaccines Historical Sales by Application (2018-2024)
5.1.2 Global Inactivated Polio and Rabies Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Polio and Rabies Vaccines Revenue by Application
5.2.1 Global Inactivated Polio and Rabies Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global Inactivated Polio and Rabies Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Polio and Rabies Vaccines Price by Application
5.3.1 Global Inactivated Polio and Rabies Vaccines Price by Application (2018-2024)
5.3.2 Global Inactivated Polio and Rabies Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Inactivated Polio and Rabies Vaccines Market Size by Type
6.1.1 US & Canada Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Inactivated Polio and Rabies Vaccines Market Size by Application
6.2.1 US & Canada Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Inactivated Polio and Rabies Vaccines Market Size by Country
6.3.1 US & Canada Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Inactivated Polio and Rabies Vaccines Market Size by Type
7.1.1 Europe Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
7.1.2 Europe Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
7.2 Europe Inactivated Polio and Rabies Vaccines Market Size by Application
7.2.1 Europe Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
7.2.2 Europe Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
7.3 Europe Inactivated Polio and Rabies Vaccines Market Size by Country
7.3.1 Europe Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
7.3.3 Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Inactivated Polio and Rabies Vaccines Market Size
8.1.1 China Inactivated Polio and Rabies Vaccines Sales (2018-2029)
8.1.2 China Inactivated Polio and Rabies Vaccines Revenue (2018-2029)
8.2 China Inactivated Polio and Rabies Vaccines Market Size by Application
8.2.1 China Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
8.2.2 China Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inactivated Polio and Rabies Vaccines Market Size by Type
9.1.1 Asia Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
9.1.2 Asia Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
9.2 Asia Inactivated Polio and Rabies Vaccines Market Size by Application
9.2.1 Asia Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
9.2.2 Asia Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
9.3 Asia Inactivated Polio and Rabies Vaccines Sales by Region
9.3.1 Asia Inactivated Polio and Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Inactivated Polio and Rabies Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Company Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 BIO-MED
11.2.1 BIO-MED Company Information
11.2.2 BIO-MED Overview
11.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BIO-MED Recent Developments
11.3 Serum Institute of India
11.3.1 Serum Institute of India Company Information
11.3.2 Serum Institute of India Overview
11.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Serum Institute of India Recent Developments
11.4 Kedrion Biopharma
11.4.1 Kedrion Biopharma Company Information
11.4.2 Kedrion Biopharma Overview
11.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion Biopharma Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Overview
11.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Recent Developments
11.6 Merck
11.6.1 Merck Company Information
11.6.2 Merck Overview
11.6.3 Merck Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Merck Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Information
11.7.2 Pfizer Overview
11.7.3 Pfizer Inactivated Polio and Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Pfizer Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inactivated Polio and Rabies Vaccines Industry Chain Analysis
12.2 Inactivated Polio and Rabies Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inactivated Polio and Rabies Vaccines Production Mode & Process
12.4 Inactivated Polio and Rabies Vaccines Sales and Marketing
12.4.1 Inactivated Polio and Rabies Vaccines Sales Channels
12.4.2 Inactivated Polio and Rabies Vaccines Distributors
12.5 Inactivated Polio and Rabies Vaccines Customers
13 Market Dynamics
13.1 Inactivated Polio and Rabies Vaccines Industry Trends
13.2 Inactivated Polio and Rabies Vaccines Market Drivers
13.3 Inactivated Polio and Rabies Vaccines Market Challenges
13.4 Inactivated Polio and Rabies Vaccines Market Restraints
14 Key Findings in The Global Inactivated Polio and Rabies Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine
Table 3. Major Manufacturers of Inactivated Rabies Vaccine
Table 4. Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2024-2029)
Table 10. Global Inactivated Polio and Rabies Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (K Dose)
Table 12. Global Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 13. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2024-2029)
Table 15. Global Inactivated Polio and Rabies Vaccines Sales by Manufacturers (2018-2024) & (K Dose)
Table 16. Global Inactivated Polio and Rabies Vaccines Sales Share by Manufacturers (2018-2024)
Table 17. Global Inactivated Polio and Rabies Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Inactivated Polio and Rabies Vaccines Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Inactivated Polio and Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Inactivated Polio and Rabies Vaccines Price by Manufacturers 2018-2024 (US$/Dose)
Table 21. Global Inactivated Polio and Rabies Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inactivated Polio and Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Polio and Rabies Vaccines as of 2022)
Table 23. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Product Offered and Application
Table 25. Global Key Manufacturers of Inactivated Polio and Rabies Vaccines, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 28. Global Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 29. Global Inactivated Polio and Rabies Vaccines Sales Share by Type (2018-2024)
Table 30. Global Inactivated Polio and Rabies Vaccines Sales Share by Type (2024-2029)
Table 31. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Inactivated Polio and Rabies Vaccines Revenue Share by Type (2018-2024)
Table 34. Global Inactivated Polio and Rabies Vaccines Revenue Share by Type (2024-2029)
Table 35. Inactivated Polio and Rabies Vaccines Price by Type (2018-2024) & (US$/Dose)
Table 36. Global Inactivated Polio and Rabies Vaccines Price Forecast by Type (2024-2029) & (US$/Dose)
Table 37. Global Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 38. Global Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 39. Global Inactivated Polio and Rabies Vaccines Sales Share by Application (2018-2024)
Table 40. Global Inactivated Polio and Rabies Vaccines Sales Share by Application (2024-2029)
Table 41. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Inactivated Polio and Rabies Vaccines Revenue Share by Application (2018-2024)
Table 44. Global Inactivated Polio and Rabies Vaccines Revenue Share by Application (2024-2029)
Table 45. Inactivated Polio and Rabies Vaccines Price by Application (2018-2024) & (US$/Dose)
Table 46. Global Inactivated Polio and Rabies Vaccines Price Forecast by Application (2024-2029) & (US$/Dose)
Table 47. US & Canada Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 48. US & Canada Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 49. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 52. US & Canada Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 53. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 59. US & Canada Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 60. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 61. Europe Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 62. Europe Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 65. Europe Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 66. Europe Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 72. Europe Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 73. China Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 74. China Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 75. China Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 78. China Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 79. China Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 82. Asia Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 83. Asia Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 86. Asia Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 87. Asia Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Inactivated Polio and Rabies Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Inactivated Polio and Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Inactivated Polio and Rabies Vaccines Sales by Region (2018-2024) & (K Dose)
Table 93. Asia Inactivated Polio and Rabies Vaccines Sales by Region (2024-2029) & (K Dose)
Table 94. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2018-2024) & (K Dose)
Table 95. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Type (2024-2029) & (K Dose)
Table 96. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2018-2024) & (K Dose)
Table 99. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Application (2024-2029) & (K Dose)
Table 100. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2018-2024) & (K Dose)
Table 106. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales by Country (2024-2029) & (K Dose)
Table 107. Bharat Biotech Company Information
Table 108. Bharat Biotech Description and Major Businesses
Table 109. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 110. Bharat Biotech Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bharat Biotech Recent Developments
Table 112. BIO-MED Company Information
Table 113. BIO-MED Description and Major Businesses
Table 114. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 115. BIO-MED Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BIO-MED Recent Developments
Table 117. Serum Institute of India Company Information
Table 118. Serum Institute of India Description and Major Businesses
Table 119. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 120. Serum Institute of India Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Serum Institute of India Recent Developments
Table 122. Kedrion Biopharma Company Information
Table 123. Kedrion Biopharma Description and Major Businesses
Table 124. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 125. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Kedrion Biopharma Recent Developments
Table 127. GlaxoSmithKline Company Information
Table 128. GlaxoSmithKline Description and Major Businesses
Table 129. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 130. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. GlaxoSmithKline Recent Developments
Table 132. Merck Company Information
Table 133. Merck Description and Major Businesses
Table 134. Merck Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 135. Merck Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Merck Recent Developments
Table 137. Pfizer Company Information
Table 138. Pfizer Description and Major Businesses
Table 139. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2018-2024)
Table 140. Pfizer Inactivated Polio and Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Pfizer Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Inactivated Polio and Rabies Vaccines Distributors List
Table 145. Inactivated Polio and Rabies Vaccines Customers List
Table 146. Inactivated Polio and Rabies Vaccines Market Trends
Table 147. Inactivated Polio and Rabies Vaccines Market Drivers
Table 148. Inactivated Polio and Rabies Vaccines Market Challenges
Table 149. Inactivated Polio and Rabies Vaccines Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Polio and Rabies Vaccines Product Picture
Figure 2. Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inactivated Polio and Rabies Vaccines Market Share by Type in 2022 & 2029
Figure 4. Inactivated Polio Vaccine Product Picture
Figure 5. Inactivated Rabies Vaccine Product Picture
Figure 6. Global Inactivated Polio and Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Inactivated Polio and Rabies Vaccines Market Share by Application in 2022 & 2029
Figure 8. Pediatrics
Figure 9. Adults
Figure 10. Inactivated Polio and Rabies Vaccines Report Years Considered
Figure 11. Global Inactivated Polio and Rabies Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Inactivated Polio and Rabies Vaccines Revenue 2018-2029 (US$ Million)
Figure 13. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Region (2018-2029)
Figure 15. Global Inactivated Polio and Rabies Vaccines Sales 2018-2029 ((K Dose)
Figure 16. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Inactivated Polio and Rabies Vaccines Sales YoY (2018-2029) & (K Dose)
Figure 18. US & Canada Inactivated Polio and Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Inactivated Polio and Rabies Vaccines Sales YoY (2018-2029) & (K Dose)
Figure 20. Europe Inactivated Polio and Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Inactivated Polio and Rabies Vaccines Sales YoY (2018-2029) & (K Dose)
Figure 22. China Inactivated Polio and Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Inactivated Polio and Rabies Vaccines Sales YoY (2018-2029) & (K Dose)
Figure 24. Asia (excluding China) Inactivated Polio and Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales YoY (2018-2029) & (K Dose)
Figure 26. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Inactivated Polio and Rabies Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Inactivated Polio and Rabies Vaccines in the World: Market Share by Inactivated Polio and Rabies Vaccines Revenue in 2022
Figure 29. Global Inactivated Polio and Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 31. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 32. Global Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 33. Global Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Inactivated Polio and Rabies Vaccines Revenue Share by Country (2018-2029)
Figure 39. US & Canada Inactivated Polio and Rabies Vaccines Sales Share by Country (2018-2029)
Figure 40. U.S. Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 43. Europe Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 44. Europe Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 45. Europe Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 46. Europe Inactivated Polio and Rabies Vaccines Revenue Share by Country (2018-2029)
Figure 47. Europe Inactivated Polio and Rabies Vaccines Sales Share by Country (2018-2029)
Figure 48. Germany Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 49. France Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 53. China Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 54. China Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 55. China Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 56. China Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 57. Asia Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 58. Asia Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 59. Asia Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 60. Asia Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 61. Asia Inactivated Polio and Rabies Vaccines Revenue Share by Region (2018-2029)
Figure 62. Asia Inactivated Polio and Rabies Vaccines Sales Share by Region (2018-2029)
Figure 63. Japan Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 67. India Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Inactivated Polio and Rabies Vaccines Sales Share by Country (2018-2029)
Figure 74. Brazil Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Inactivated Polio and Rabies Vaccines Revenue (2018-2029) & (US$ Million)
Figure 79. Inactivated Polio and Rabies Vaccines Value Chain
Figure 80. Inactivated Polio and Rabies Vaccines Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries